Home › Funds › ADAR1 Capital Management, LLC › SRPT
ADAR1 Capital Management, LLC position in SRPT
SAREPTA THERAPEUTICS INC · Health Care
ADAR1 Capital Management, LLC reported holding 952,063 shares of SRPT (SAREPTA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$17.3M, representing 0.95% of its reported portfolio and ranking #23 among its reported holdings. ADAR1 Capital Management, LLC has disclosed SRPT holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ADAR1 Capital Management, LLC's SRPT position evolved
ADAR1 Capital Management, LLC first disclosed a stake in SRPT in Q4 2023 at 8,062 shares (US$777K). The position peaked in Q3 2026 at 952,063 shares, worth US$17.3M. Across 12 filings, ADAR1 Capital Management, LLC increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 952,063 shares valued at US$17.3M — an increase of 221,414 shares quarter over quarter.. Notable position changes include a 463% increase in Q4 2024 (shares fell 48% over the following quarter), a 536% increase in Q3 2025 (shares rose 12% over the following quarter), a 808% increase in Q1 2026 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 8.06K | $777.42K | New |
| Q1 2024 | 1.20K | $155.35K | Reduce |
| Q2 2024 | 4.45K | $703.10K | Add |
| Q3 2024 | 7.10K | $886.72K | Add |
| Q4 2024 | 40.00K | $4.86M | Add |
| Q1 2025 | 122.92K | $7.84M | Add |
| Q2 2025 | 55.00K | $940.50K | Reduce |
| Q3 2025 | 349.81K | $6.74M | Add |
| Q4 2025 | 28.87K | $621.20K | Reduce |
| Q1 2026 | 262.06K | $5.70M | Add |
| Q2 2026 | 730.65K | $13.13M | Add |
| Q3 2026 | 952.06K | $17.35M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRPT and 13F data
SRPT (SAREPTA THERAPEUTICS INC) is a Health Care company. 12 other funds we track also report a position in SRPT — the largest reported positions include HIGHBRIDGE CAPITAL MANAGEMENT LLC (US$50.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SRPT
- HIGHBRIDGE CAPITAL MANAGEMENT LLC 52.31M sh · $50.34M · Q3 2026
More on ADAR1 Capital Management, LLC
FAQ
How long has ADAR1 Capital Management, LLC held SRPT?
ADAR1 Capital Management, LLC has disclosed SRPT holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is ADAR1 Capital Management, LLC's current position in SRPT?
As of Q3 2026, ADAR1 Capital Management, LLC holds 952.06K shares of SRPT (SAREPTA THERAPEUTICS INC), valued at $17.35M, representing 0.95% of its reported portfolio and ranking #23.
Has ADAR1 Capital Management, LLC been buying or selling SRPT?
In the latest 13F filing (Q3 2026), ADAR1 Capital Management, LLC increased its position in SRPT. The position peaked in Q3 2026 at 952.06K shares.
Which other funds hold SRPT?
Other major institutional holders of SRPT include HIGHBRIDGE CAPITAL MANAGEMENT LLC, among 12 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.